Experimental Cancer Treatment Works Like A “Vaccine”:
One of the oldest forms of treating a serious disease is the idea of a Vaccination.
Give your body a weak microdose of something, let it react & “learn” the disease to respond to it full-force if it ever happens for real.
For the most serious problems out there, a 1-shot-deal sure looks like a dream fix.
Unfortunately, when it comes to The Big C, most of the experimental fixes we get are putting some concentrated stuff on extracted-cells in a petri-dish.
But that’s not what Ron Levy’s team did at Stanford, and the results are cautiously promising…
Apparently Not The Same-Old Experiment:
So as stated before, most of the new treatments we hear about are so experimental, they don’t seem practical at-all.
But the Levy trials were apparently nothing like that.
-Which you might expect, because Ron is a trailblazer in the field of immunotherapy, so new & different is just his wheelhouse.
The new & different serum they came up with was comprised of just 2 compounds, called CpG and
And it’s injected directly into the problem areas of actual living things.
Direct Application To The Problem:
These compounds then stimulated the immune system to target that location.
And miraculously, it proceeded to kill the entire problem-spot.
One more thing,
Without even additional application of the 2 “vaccine” factors, it turns out that after being “trained”,
The immune system went around and killed all the other cancer-sites in the animal’s body,
Including some problem areas that were in the tiniest beginning-stages of becoming an issue.
-Hence the informal handle of “vaccine”.
Because it takes care of more-or-less all the problems of one type; even the ones that are least-likely to be found!
Stanford Formula Turns Your Whole Immune-System Into A Cancer Vaccine:
It was also 97% effective.
Wait, it gets worse; and by “worse”, I mean even better.
It turned out that 3% of the test animals had recurrences.
So the team just injected them a 2nd time.
And then all the recurrences were eradicated, too.
It Works On More Than 1 Type:
Still more good news.
It doesn’t just work on Lymph-Cell problems.
They also did experiments on Breast, Colon, & Skin lesions, too.
And the “vaccine” worked on all 3 of those types as well.
But what about time, cost, & complexity?
Some of the more traditional, or even recent treatments for The Big C come with several complications.
What About The Complicated Logistics Of Treatment?:
They involve a great deal of time, can require lengthy prep-work for some immunotherapies like CAR-T in collecting & modifying a person’s own cells,
And in the case of Immuno- and Chemo- therapies, they have wide-scale side-effects that spread across the whole body.
The Levy Vaccine approach doesn’t involve any of these, as the 2-part-mix is already formulated on-hand and doesn’t require culturing of the recipient’s own cells.
It’s also extremely-localized so that it only goes to one place, and then has follow-on effects for the exact same type of irregularities in the recipient.
So in-comparison, the application & prep-speed can be faster, it can cost less, cause fewer whole-body side-effects, and take action very fast once-administered.
Anywhere You Can Get The Needle, You Can Probably Treat:
And perhaps the cleverest bit of all is the Targeting.
Because the treatment gets the immune-system to go after the exact type of problem the fix is injected into,
Anywhere you can get that needle is a place that you can potentially treat.
And Dr. Levy believes there is almost no type of cancer that cannot be treated because of that fact.
So for something that looks this amazing, we’d normally want to freak right-the-hell-out & say, “Shot Heard Round The World”.
But let’s just hope cautiously, with all our fingers-crossed, that the vaccine approach works for real people in the upcoming human trials.
Because the Levy “cancer vaccine” sure looks like it solves a Ton of problems very effectively!
Corrections, Additions, etc.: “OX40” corrected to “Anti-OX40”, 4/17/21.
• Source: Stanford
• More Coverage: Stanford-Cancer “Vaccine” Human Trials Signup For Non-Hodgkin Lymphoma
• Source Study: Science Translational Med. – Eradication of spontaneous malignancy by local immunotherapy